新divOP :
It's a deficit company that is a deficit company It's up 260% year to date. Biotech manufacturers There are no sales due to financial results. But analysts' reviews are good and they are bullish A company that is raising expectations. I'm worried that medicine is being sold There is,
新divOP : It's a deficit company that is a deficit company
It's up 260% year to date.
Biotech manufacturers
There are no sales due to financial results.
But analysts' reviews are good and they are bullish
A company that is raising expectations.
I'm worried that medicine is being sold
There is,